Clinical Cancer Research, Vol 1, Issue 2 235-243, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells

JM Gudas, RC Klein, M Oka and KH Cowan
Medicine Branch, Division of Cancer Treatment, Medical Breast Cancer Section, National Cancer Institute, Bethesda, Maryland 20892, USA.

We have determined that expression of the c-myb proto-oncogene is associated with estrogen receptor (ER) status and not with tumor progression in human breast epithelial cells. Analysis of normal, immortalized, nontumorigenic, and tumorigenic mammary epithelial cells showed that only ER+ tumor cell lines expressed readily detectable levels of c-myb mRNA and a Mr 75,000 protein that was the same size as the c-myb transcripts and protein products present in hematopoietic cells. In this report we show that c-myb mRNA and protein levels are down-regulated during estrogen withdrawal. A 20-fold increase in c-myb mRNA and protein expression was observed upon addition of beta-estradiol to the culture medium. Nuclear run-on transcription analyses showed that c-myb was transcribed at the same rate in the presence and absence of estrogen, suggesting that c-myb mRNA accumulation was regulated at a posttranscriptional level. To provide additional evidence that c-myb mRNA was dependent on ER expression, we examined c-myb mRNA levels in MCF-7 cells selected for resistance to antineoplastic drugs. c-myb expression was decreased only in cell lines that showed concomitant loss of ER expression. Moreover, c-myb mRNA was expressed and modulated by estrogen in ER-, MDA-MB-231 cells stably transfected with a human ER gene. When considered together, these data indicate that c-myb mRNA levels are regulated by estrogens and further suggest that this proto-oncogene plays a role in the biology of ER+ breast tumor cells.

This article has been cited by other articles:

				J. A. Ronneberg, J. Tost, H. K. Solvang, G. I.G. Alnaes, F. E. Johansen, E. M. Brendeford, Z. Yakhini, I. G. Gut, P. E. Lonning, A.-L. Borresen-Dale, et al. GSTP1 Promoter Haplotypes Affect DNA Methylation Levels and Promoter Activity in Breast Carcinomas Cancer Res., July 15, 2008; 68(14): 5562 - 5571. [Abstract] [Full Text] [PDF]

				G. W. Woodfield, A. D. Horan, Y. Chen, and R. J. Weigel TFAP2C Controls Hormone Response in Breast Cancer Cells through Multiple Pathways of Estrogen Signaling Cancer Res., September 15, 2007; 67(18): 8439 - 8443. [Abstract] [Full Text] [PDF]

				Y. Drabsch, H. Hugo, R. Zhang, D. H. Dowhan, Y. R. Miao, A. M. Gewirtz, S. C. Barry, R. G. Ramsay, and T. J. Gonda Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells PNAS, August 21, 2007; 104(34): 13762 - 13767. [Abstract] [Full Text] [PDF]

				J. Xu, S. Fan, and E. M. Rosen Regulation of the Estrogen-Inducible Gene Expression Profile by the Breast Cancer Susceptibility Gene BRCA1 Endocrinology, April 1, 2005; 146(4): 2031 - 2047. [Abstract] [Full Text] [PDF]

				C. Sotiriou, S.-Y. Neo, L. M. McShane, E. L. Korn, P. M. Long, A. Jazaeri, P. Martiat, S. B. Fox, A. L. Harris, and E. T. Liu Breast cancer classification and prognosis based on gene expression profiles from a population-based study PNAS, September 2, 2003; 100(18): 10393 - 10398. [Abstract] [Full Text] [PDF]

				M. West, C. Blanchette, H. Dressman, E. Huang, S. Ishida, R. Spang, H. Zuzan, J. A. Olson Jr., J. R. Marks, and J. R. Nevins Predicting the clinical status of human breast cancer by using gene expression profiles PNAS, September 13, 2001; (2001) 201162998. [Abstract] [Full Text] [PDF]

				P. Kauraniemi, I. Hedenfalk, K. Persson, D. J. Duggan, M. Tanner, O. Johannsson, H. Olsson, J. M. Trent, J. Isola, and A. Borg MYB Oncogene Amplification in Hereditary BRCA1 Breast Cancer Cancer Res., October 1, 2000; 60(19): 5323 - 5328. [Abstract] [Full Text]

				M. West, C. Blanchette, H. Dressman, E. Huang, S. Ishida, R. Spang, H. Zuzan, J. A. Olson Jr., J. R. Marks, and J. R. Nevins Predicting the clinical status of human breast cancer by using gene expression profiles PNAS, September 25, 2001; 98(20): 11462 - 11467. [Abstract] [Full Text] [PDF]